Clinical trial
Can Injection of Methylprednisoloneacetate 80 mg, in the Cavity After Mastectomy for Primary Breast Cancer, at the Time of Removal of the Drain, Prevent Seroma Formation?
NCT01380912 is registered in ClinicalTrials.gov with Copenhagen University Hospital at Herlev as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Injection of Methylprednisoloneacetate 80 mg, in the Cavity After Mastectomy for Primary Breast Cancer, at the Time of Removal of the Drain, Prevent Seroma Formation?
- Lead sponsor
- Copenhagen University Hospital at Herlev
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2010
- Completion date
- August 31, 2012
- Enrollment
- 160 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer